Cargando…
Comorbidities and Complications in Idiopathic Pulmonary Fibrosis
Though idiopathic pulmonary fibrosis (IPF) is characterized by single-organ involvement, many comorbid conditions occur within other organ systems. Patients with IPF may present during evolution different complications and comorbidities that influence the prognosis and modify the natural course of t...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163702/ https://www.ncbi.nlm.nih.gov/pubmed/30200249 http://dx.doi.org/10.3390/medsci6030071 |
_version_ | 1783359424810713088 |
---|---|
author | Cano-Jiménez, Esteban Hernández González, Fernanda Peloche, Guadalupe Bermudo |
author_facet | Cano-Jiménez, Esteban Hernández González, Fernanda Peloche, Guadalupe Bermudo |
author_sort | Cano-Jiménez, Esteban |
collection | PubMed |
description | Though idiopathic pulmonary fibrosis (IPF) is characterized by single-organ involvement, many comorbid conditions occur within other organ systems. Patients with IPF may present during evolution different complications and comorbidities that influence the prognosis and modify the natural course of their disease. In this chapter, we highlight common comorbid conditions encountered in IPF, discuss disease-specific diagnostic modalities, and review the current treatment data for several key comorbidities. The diagnosis and treatment of these comorbidities is a challenge for the pulmonologist specialized in interstitial lung diseases (ILDs). We will focus on pulmonary emphysema, lung cancer, gastroesophageal reflux, pulmonary hypertension, obstructive sleep apnea (sleep disorders), and acute exacerbation of IPF. |
format | Online Article Text |
id | pubmed-6163702 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61637022018-10-10 Comorbidities and Complications in Idiopathic Pulmonary Fibrosis Cano-Jiménez, Esteban Hernández González, Fernanda Peloche, Guadalupe Bermudo Med Sci (Basel) Review Though idiopathic pulmonary fibrosis (IPF) is characterized by single-organ involvement, many comorbid conditions occur within other organ systems. Patients with IPF may present during evolution different complications and comorbidities that influence the prognosis and modify the natural course of their disease. In this chapter, we highlight common comorbid conditions encountered in IPF, discuss disease-specific diagnostic modalities, and review the current treatment data for several key comorbidities. The diagnosis and treatment of these comorbidities is a challenge for the pulmonologist specialized in interstitial lung diseases (ILDs). We will focus on pulmonary emphysema, lung cancer, gastroesophageal reflux, pulmonary hypertension, obstructive sleep apnea (sleep disorders), and acute exacerbation of IPF. MDPI 2018-08-30 /pmc/articles/PMC6163702/ /pubmed/30200249 http://dx.doi.org/10.3390/medsci6030071 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Cano-Jiménez, Esteban Hernández González, Fernanda Peloche, Guadalupe Bermudo Comorbidities and Complications in Idiopathic Pulmonary Fibrosis |
title | Comorbidities and Complications in Idiopathic Pulmonary Fibrosis |
title_full | Comorbidities and Complications in Idiopathic Pulmonary Fibrosis |
title_fullStr | Comorbidities and Complications in Idiopathic Pulmonary Fibrosis |
title_full_unstemmed | Comorbidities and Complications in Idiopathic Pulmonary Fibrosis |
title_short | Comorbidities and Complications in Idiopathic Pulmonary Fibrosis |
title_sort | comorbidities and complications in idiopathic pulmonary fibrosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163702/ https://www.ncbi.nlm.nih.gov/pubmed/30200249 http://dx.doi.org/10.3390/medsci6030071 |
work_keys_str_mv | AT canojimenezesteban comorbiditiesandcomplicationsinidiopathicpulmonaryfibrosis AT hernandezgonzalezfernanda comorbiditiesandcomplicationsinidiopathicpulmonaryfibrosis AT pelocheguadalupebermudo comorbiditiesandcomplicationsinidiopathicpulmonaryfibrosis |